EULAR QoC Ongoing Initiatives
 
  • QoC058 - Update of the EULAR recommendations for the Management of Psoriatic Arthrities with Pharmacological Therapies
    Josef Smolen     
     
  • QoC057 - EULAR Points to Consider for the Definition of Undifferentiated Connective Tissue Disease (UCTD)
    Marta Mosca / Sarah Dyball
     
  • QoC056 - EULAR recommendations for the management of Sjögren’s disease with topical and systemic therapies: an update
    Roberto Giacomelli / Athanasios Tzioufas

  • QoC055 - EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis – 2026 Update
    Peter Mandl / Philip Conaghan

  • QoC054 - EULAR points to consider for the definition of difficult-to-manage systemic sclerosis
    Muriel Elhai / Oliver Distler 

  • QoC053 (IMPL) - Implementing Brief Assessments and Interventions for Physical Activity and Sedentary Behaviour to Rheumatology Care
    Anne Kathrin Rausch / Leti van Bodegom /  Keegan Knittle

  • QoC052 - Update of the 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
    Annette de Thurah / Christian Dejaco

  • QoC051 - 2026 Update – EULAR Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis
    Ingrid Larsson / Bente Appel Esbensen

  • QoC050 - EULAR recommendations for the management of calcium pyrophosphate deposition disease
    Giorgios Filippou / Tristan Pascart

  • QoC049 - EULAR definition of treatment-refractory manifestations of Systemic lupus erythematosus
    Maria Tektonidou

  • QoC048 - EULAR-ACR Classification Criteria for Novel, living risk stratification for systemic lupus erythematosus
    M. Moca / K. Costenbader

  • QoC047 (NON TF) - EULAR HARMONY-RHEUM initiative: Harmonizing Terminology in Rheumatology to Improve Communication and Quality of Care (non - task force project)
    G. Fragoulis / X. Baraliakos / U. Kiltz

  • QoC046 (IMPL) - AIRA - Assessment, Intervention and Re-Assessment of the ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update, IMPLEMENTATION PROJECT
    K. Schreiber / S. Ramiro

  • QoC045 - Development of EULAR recommendations for cardiorespiratory fitness in people with Rheumatic and Musculoskeletal Diseases
    T. WillemSwinnen / K. Nordén
     
  • QoC044 - EULAR-ERA recommendations for the management of ANCA-associated vasculitis: 2027 update
    B. Hellmich / D. Jayne  

  • QoC043 - EULAR points to consider for the diagnosis and management of IgG4-related disease
    U. Kiltz / E. Della Torre   

  • QoC042 -  EULAR recommendations for the management of idiopathic inflammatory myopathies in adults
    P. Machado / I. Lundberg
     
     
  • QoC041 - Update of EULAR Recommendations for the Management of Fibromyalgia
    Gary Macfarlane 

  • QoC040 - Points to consider: Use of CAR-based therapies and T cell engagers in inflammatory rheumatic diseases
    M. Scherlinger / J. Avouac 

  • QoC039 -  Update of the EULAR points to consider/recommendations for the use of Artificial Intelligence and Big Data in RMDs
    G. Burmester / L. Gupta 


  • QoC038 (IMPL) - Implementing the updated EULAR recommendations for patient research partner involvement in research: the INSPIRE initiative (Implementing New Strategies for PRP Involvement in Research at EULAR)
    Muriel Elhai / Krystel Aouad

  • QoC037 -  EULAR recommendations for the management of gout: 2027 update
    Abhishek Abhishek / Richette Pascal

  • QoC035 (IMPL) - Piloting a Pragmatic Dissemination and Early Implementation Model for EULAR Recommendations/Points to Consider, IMPLEMENTATION PROJECT
    Fernando Estevez Lopez / Nina Østerås / Rafael Prieto-Moreno

  • QoC034 -  EULAR-ACR Development and Validation of a Revised Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies
    Ingrid Lundberg (EULAR) / Rohit Aggarwal (ACR) 
     
  • QoC033 - Update of the EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatic and Musculoskeletal Diseases
    Mike Nurmohamed / Maria Tektonidou 

  • QoC032 - EULAR recommendations for the assessment of malignancy risk in autoimmune rheumatic diseases
    Elena Nikiphorou

  • QoC031 - EULAR points to consider on the combination of targeted therapies in patients with inflammatory arthritis or systemic autoimmune rheumatic diseases
    J.E. Gottenberg / T. Pham

  • QoC030 - 202X update of the EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
    Hendrik Schulze/ Koops / Jacques E. Gottenberg

  • QoC026 - EULAR recommendations for the screening and management of osteoporosis in patients with inflammatory rheumatic musculoskeletal diseases (iRMDs)
    Frank Buttgereit / Giovanni Adami 

  • QoC017 - EULAR Points to Consider on risk stratification of populations for RA prevention studies: new inclusion of ACR collaboration and population-based approaches to risk stratification
    Kevin Deane / Kulveer Mankia/ A. Van der Helm / Karim Raza

  • QoC014 - ACR-EULAR Development of Classification Criteria for Immune Related Adverse Events: Inflammatory Arthritis
    A.Meara / M.Kostine

  • QoC004 - Development of EULAR/ACR Criteria for Disease Activity and Response in Giant Cell Arteritis
    Dejaco / Langford 

  • CLI098 - ACR-EULAR Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Peter Merkel / Gunnar Tomasson

  • CLI088 - The Development of New Classification Criteria for Hand Osteoarthritis
    Margreet Kloppenburg

  • IMG013 - EULAR Recommendations for the use of imaging in patient with mechanical back pain
    Gilles Fournier
 
Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more


EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more